1. Comparison between the clot-protecting activity of a mutant plasminogen activator inhibitor-1 with a very long half-life and 6-aminocaproic acid
   DANIEL GLENN KINDELL et al, 2015, Experimental and Therapeutic Medicine CrossRef
2. S2′‐subsite variations between human and mouse enzymes (plasmin, factor XIa, kallikrein) elucidate inhibition differences by tissue factor pathway inhibitor ‐2 domain1‐wild‐type, Leu17Arg‐mutant and aprotinin
   K. Vadivel et al, 2016, Journal of Thrombosis and Haemostasis CrossRef
3. Fibrinolytic Serine Proteases, Therapeutic Serpins and Inflammation: Fire Dancers and Firestorms
   Jordan R. Yaron et al, 2021, Frontiers in Cardiovascular Medicine CrossRef
4. Unusual clotting dynamics of plasma supplemented with iron(III)
   JERZY JANKUN et al, 2014, International Journal of Molecular Medicine CrossRef
5. Inhibition of Fibrinolysis by Streptococcal Phage Lysin SM1
   Hyun Jung Ji et al, 2021, mBio CrossRef
6. The plasminogen activation system in periodontal tissue (Review)
   MARZENA WYGANOWSKA-ŚWIĄTKOWSKA et al, 2014, International Journal of Molecular Medicine CrossRef
7. Glucocorticoid-Responsive Tissue Plasminogen Activator (tPA) and Its Inhibitor Plasminogen Activator Inhibitor-1 (PAI-1): Relevance in Stress-Related Psychiatric Disorders
   Marie Mennesson et al, 2023, International Journal of Molecular Sciences CrossRef
8. Serum Proteomic Signature of Human Chagasic Patients for the Identification of Novel Potential Protein Biomarkers of Disease
   Jian-Jun Wen et al, 2012, Molecular & Cellular Proteomics CrossRef
9. Enhanced Antifibrinolytic Efficacy of a Plasmin-Specific Kunitz-Inhibitor (60-Residue Y11T/L17R with C-Terminal IEK) of Human Tissue Factor Pathway Inhibitor Type-2 Domain1
   Kanagasabai Vadivel et al, 2020, Journal of Clinical Medicine CrossRef
10. Designing rt-PA Analogs to Release its Trapped Thrombolytic Activity
    Wei Li, 2021, Journal of Computational Biophysics and Chemistry CrossRef